The DOI matches its Crossref record; 478 of the 478 references it cites were found in a registry or an index.
Realistic expectations of prepulse inhibition in translational models for schizophrenia research
Open accessAbstract
Introduction Under specific conditions, a weak lead stimulus, or "prepulse", can inhibit the startling effects of a subsequent intense abrupt stimulus. This startle-inhibiting effect of the prepulse, termed "prepulse inhibition" (PPI), is widely used in translational models to understand the biology of brainbased inhibitory mechanisms and their deficiency in neuropsychiatric disorders. In 1981, four published reports with "prepulse inhibition" as an index term were listed on Medline; over the past 5 years, new published Medline reports with "prepulse inhibition" as an index term have appeared at a rate exceeding once every 2.7 days (n=678). Most of these reports focus on the use of PPI in translational models of impaired sensorimotor gating in schizophrenia. This rapid expansion and broad application of PPI as a tool for understanding schizophrenia has, at times, outpaced critical thinking and falsifiable hypotheses about the relative strengths vs. limitations of this measure.Objectives This review enumerates the realistic expectations for PPI in translational models for schizophrenia research, and provides cautionary notes for the future applications of this important research tool.Conclusion In humans, PPI is not "diagnostic"; levels of PPI do not predict clinical course, specific symptoms, or individual medication responses. In preclinical studies, PPI is valuable for evaluating models or model organisms relevant to schizophrenia, "mapping" neural substrates of deficient PPI in schizophrenia, and advancing the discovery and development of novel therapeutics. Across species, PPI is a reliable, robust quantitative phenotype that is useful for probing the neurobiology and genetics of gating deficits in schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“normalizing PPI deficits in rodent models has enabled drug discovery for potential antipsychotic medications [371], some of which have proven successful in treating schizophrenia [368,372].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [368]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
Gottesman, I. I., & Gould, T. D. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.636 · Cited by 5,615
Dementia Praecox or the Group of Schizophrenias
(1951) · Journal of the American Medical Association · doi:10.1001/jama.1951.02920270079043 · Cited by 4,407
Dementia Praecox and Paraphrenia.
(1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-6-1058_8 · Cited by 2,907
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
BRAFF, D. L., Geyer, M. A., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100810 · Cited by 1,701
Self-citationGeyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484
Self-citationLacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G., & Jeste, D. V. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1007 · Cited by 1,383
Cannon, T. D., Cadenhead, K., Cornblatt, B., Woods, S. W., Addington, J., Walker, E., Seidman, L. J., Perkins, D., Tsuang, M., McGlashan, T., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.3 · Cited by 1,269
Disorders of attention and perception in early schizophrenia
McGhie, A., & Chapman, J. (1961) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1961.tb00936.x · Cited by 1,195
Prestimulus Effects on Human Startle Reflex in Normals and Schizophrenics
BRAFF, D. L., Stone, C., Callaway, E., Geyer, M. A., Glick, I. D., & Bali, L. (1978) · Psychophysiology · doi:10.1111/j.1469-8986.1978.tb01390.x · Cited by 1,171
Self-citationLinkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141
The more or less startling effects of weak prestimulation
Graham, F. K. (1975) · Psychophysiology · doi:10.1111/j.1469-8986.1975.tb01284.x · Cited by 1,119
Swerdlow, N. R., Geyer, M. A., & BRAFF, D. L. (2001) · Psychopharmacology · doi:10.1007/s002130100799 · Cited by 1,053
Self-citationGating and Habituation of the Startle Reflex in Schizophrenic Patients
Braff, D. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820030038005 · Cited by 1,027
Self-citationMaternal influenza infection causes marked behavioral and pharmacological changes in the offspring
Shi, L., Fatemi, S. H., Sidwell, R. W., & Patterson, P. H. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00297.2003 · Cited by 1,025
A primary acoustic startle circuit: lesion and stimulation studies
Davis, M., Gendelman, D. S., Tischler, M., & Gendelman, P. M. (1982) · Journal of Neuroscience · doi:10.1523/jneurosci.02-06-00791.1982 · Cited by 967
Carter, R. J., Lione, L. A., Humby, T., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., & Morton, A. J. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-08-03248.1999 · Cited by 949
Adler, L. E., Pachtman, E., Franks, R. D., Pecevich, M., Waldo, M. C., & Freedman, R. (1982) · PubMed · Cited by 896
Current Protocols in Neuroscience
(2018) · Current Protocols in Neuroscience · doi:10.1002/(issn)1934-8576 · Cited by 771
Assessing the Validity of an Animal Model of Deficient Sensorimotor Gating in Schizophrenic Patients
Swerdlow, N. R. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020063007 · Cited by 708
Self-citationSwerdlow, N. R., & Geyer, M. A. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033326 · Cited by 626
Self-citationDopaminergic stimulation disrupts sensorimotor gating in the rat
Mansbach, R. S., Geyer, M. A., & BRAFF, D. L. (1988) · Psychopharmacology · doi:10.1007/bf00212846 · Cited by 606
Self-citationLIBET, B., WRIGHT, E. W. W., FEINSTEIN, B., & PEARL, D. K. (1979) · Brain · doi:10.1093/brain/102.1.193 · Cited by 589 · cited 2×
“While clearly a point for more systematic analysis, such a notion suggests a biological mechanism that is syntonic with psychological models for the intrusion of unedited, preconscious content into conscious awareness in this disorder (Libet et al. 1979; Gray 1995; Swerdlow 1996; Grobstein 2005).”
BackgroundThe Mammalian Startle Response
Davis, M. (1984) · Springer eBooks · doi:10.1007/978-1-4899-2286-1_10 · Cited by 582
Behavioral phenotypes of Disc1 missense mutations in mice
Clapcote, S. J., Lipina, T. V., Millar, J. K., Mackie, S., Christie, S., Ogawa, F., Lerch, J. P., Trimble, K., Uchiyama, M., Sakuraba, Y., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.04.015 · Cited by 526
The acoustic startle response in rats—circuits mediating evocation, inhibition and potentiation
Koch, M., & Schnitzler, H. U. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)02296-1 · Cited by 521
Psychiatric endophenotypes and the development of valid animal models
Gould, T. D., & Gottesman, I. I. (2005) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2005.00186.x · Cited by 521
Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia
Miyakawa, T., Leiter, L. M., Gerber, D. J., Gainetdinov, R. R., Sotnikova, T. D., Zeng, H., Caron, M. G., & Tonegawa, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432926100 · Cited by 489
INPUT DYSFUNCTION IN SCHIZOPHRENIA.
Venables, P. H. (1964) · PubMed · Cited by 473
Ozawa, K., Hashimoto, K., Kishimoto, T., Shimizu, E., Ishikura, H., & Iyo, M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.031 · Cited by 467
BRAFF, D. L., Freedman, R., Schork, N. J., & Gottesman, I. I. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl049 · Cited by 454
Self-citationSwerdlow, N. R., Paulsen, J. S., BRAFF, D. L., Butters, N., Geyer, M. A., & Swenson, M. R. (1995) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.58.2.192 · Cited by 436
Self-citationSchneider, M., & Koch, M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300225 · Cited by 425
Neural mechanisms of startle behavior
(1987) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(87)90199-4 · Cited by 415
Mismatch Negativity Deficits Are Associated With Poor Functioning in Schizophrenia Patients
Light, G. A., & Braff, D. L. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.2.127 · Cited by 407
Self-citationSensorimotor gating in boys with Tourette's syndrome and ADHD: Preliminary results
Castellanos, F. X., Fine, E. J., Kaysen, D. L., Marsh, W., Rapoport, J. L., & Hallett, M. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00101-8 · Cited by 395
Swerdlow, N. R., BRAFF, D. L., & Geyer, M. A. (2000) · Behavioural Pharmacology · doi:10.1097/00008877-200006000-00002 · Cited by 394
Self-citationSwerdlow, N. R., Caine, S. B., BRAFF, D. L., & Geyer, M. A. (1992) · Journal of Psychopharmacology · doi:10.1177/026988119200600210 · Cited by 388
Self-citationAntipsychotic Medication Adherence: Is There a Difference Between Typical and Atypical Agents?
Dolder, C. R., Lacro, J. P., Dunn, L. B., & Jeste, D. V. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.103 · Cited by 385
Initial Heritability Analyses of Endophenotypic Measures for Schizophrenia
Greenwood, T. A., BRAFF, D. L., Light, G. A., Cadenhead, K. S., Calkins, M. E., Dobie, D. J., Freedman, R., Green, M. F., Gur, R. E., Gur, R. C., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.11.1242 · Cited by 382
Self-citationSchizophrenia-Relevant Behavioral Testing in Rodent Models: A Uniquely Human Disorder?
Powell, C. M., & Miyakawa, T. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.008 · Cited by 381
Paylor, R. E., Pourcain, B. S., Mupo, A., Ataliotis, P., Spencer, C. M., Sobotka, A., Sparks, C., Choi, C.-H., Oghalai, J. S., Curran, S. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600206103 · Cited by 381
Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat*1
Mansbach, R. S. (1989) · Neuropsychopharmacology · doi:10.1016/0893-133x(89)90035-3 · Cited by 380
Geyer, M. A., Wilkinson, L. S., Humby, T., & Robbins, T. W. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90180-l · Cited by 379
Lipska, B. K., Weinberger, D. R., Swerdlow, N. R., Geyer, M. A., BRAFF, D. L., & Jaskiw, G. E. (1995) · Psychopharmacology · doi:10.1007/bf02246439 · Cited by 356
Self-citationA preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder
Swerdlow, N. R., Benbow, C. H., Zisook, S., Geyer, M. A., & BRAFF, D. L. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90300-3 · Cited by 351
Self-citationFragile X mice develop sensory hyperreactivity to auditory stimuli
Chen, L., & Toth, M. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00036-7 · Cited by 345
Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice
Kaifu, T., Nakahara, J., Inui, M., Mishima, K., Momiyama, T., Kaji, M., Sugahara, A., Koito, H., Ujike, A., Nakamura, A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16923 · Cited by 342
Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics
Swerdlow, N. R., BRAFF, D. L., Geyer, M. A., & Koob, G. F. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90005-3 · Cited by 341
Self-citationSwerdlow, N. R., Light, G. A., Cadenhead, K. S., Sprock, J., Hsieh, M. H., & Braff, D. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.12.1325 · Cited by 339
Self-citationEvidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia
Mukai, J., Liu, H., Burt, R., Swor, D. E., Lai, W., Karayiorgou, M., & Gogos, J. A. (2004) · Nature Genetics · doi:10.1038/ng1375 · Cited by 315
Raamsdonk, J. M. V., Pearson, J., Slow, E., Hossain, S. M., Leavitt, B. R., & Hayden, M. R. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0590-05.2005 · Cited by 315
Diverse Psychotomimetics Act Through a Common Signaling Pathway
Svenningsson, P., Tzavara, E. T., Carruthers, R., Rachleff, I., Wattler, S., Nehls, M. C., McKinzie, D. L., Fienberg, A. A., Nomikos, G. G., & Greengard, P. (2003) · Science · doi:10.1126/science.1089681 · Cited by 313
Borrell, J. I. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00360-8 · Cited by 312
Information-processing deficits and thought disorder in schizophrenia
Perry, W., & BRAFF, D. L. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.3.363 · Cited by 311
Self-citationAddington, J., Cadenhead, K. S., Cannon, T. D., Cornblatt, B., McGlashan, T. H., Perkins, D. O., Seidman, L. J., Tsuang, M. T., Walker, E. F., Woods, S. W., et al. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl075 · Cited by 299
Schneider, T., Turczak, J., & Przewłocki, R. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300767 · Cited by 298
Kinney, G. G., O’Brien, J. A., Lemaire, W., Burno, M., Bickel, D. J., Clements, M. K., Chen, T., Wisnoski, D. D., Lindsley, C. W., Tiller, P. R., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.079244 · Cited by 298
Koenig, J. I., Elmer, G. I., Shepard, P. D., Lee, P. R., Mayo, C. L., Joy, B., Hercher, E., & Brady, D. L. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.05.030 · Cited by 297
Mouse genetic models for prepulse inhibition: an early review
Geyer, M. A., McIlwain, K. L., & Paylor, R. E. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001159 · Cited by 289
Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia
BRAFF, D. L., Geyer, M. A., Light, G. A., Sprock, J., Perry, W., Cadenhead, K. S., & Swerdlow, N. R. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00139-0 · Cited by 288
Self-citationSensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice.
Frankland, P. W., Wang, Y., Rosner, B., Shimizu, T., Balleine, B. W., Dykens, E. M., Ornitz, E. M., & Silva, A. J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001432 · Cited by 275
Koch, M., Kungel, M., & Herbert, H. (1993) · Experimental Brain Research · doi:10.1007/bf00228818 · Cited by 272
Grillon, C., Morgan, C. A., Davis, M., & Southwick, S. M. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00034-1 · Cited by 263
Fox, G. B., Esbenshade, T. A., Pan, J. B., Radek, R. J., Krueger, K. M., Yao, B. B., Browman, K. E., Buckley, M. J., Ballard, M. E., Komater, V. A., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078402 · Cited by 260
Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania
Perry, W., Minassian, A., Feifel, D., & Braff, D. L. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01184-2 · Cited by 260
Self-citationTremolizzo, L., Doueiri, M.-S., Dong, E., Grayson, D. R., Davis, J. M., Pinna, G., Tueting, P. A., Rodriguez‐Menendez, V., Costa, E., & Guidotti, A. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.046 · Cited by 260
Swerdlow, N. R., Hartman, P. L., & Auerbach, P. P. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00065-0 · Cited by 254
Self-citationLeppert, M., Burt, R. W., Hughes, J. P., Samowitz, W. S., Nakamura, Y., Woodward, S. R., Gardner, E. J., Lalouel, J.-M., & White, R. L. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003293221306 · Cited by 252
The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia
Wolinsky, T., Swanson, C., Smith, K. E., Zhong, H., Borowsky, B., Seeman, P., Branchek, T., & Gerald, C. (2007) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2006.00292.x · Cited by 245
Normalization of Information Processing Deficits in Schizophrenia With Clozapine
Kumari, V., Soni, W., & Sharma, T. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1046 · Cited by 245
Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia
Ludewig, K., Geyer, M. A., & Vollenweider, F. X. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01925-x · Cited by 240
Chiu, C., Brickley, S. G., Jensen, K., Southwell, A. L., McKinney, S. L., Cull-Candy, S. G., Módy, I., & Lester, H. A. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3364-04.2005 · Cited by 238
Anxiolytic-Like Properties of the Anandamide Transport Inhibitor AM404
Bortolato, M., Campolongo, P., Mangieri, R. A., Scattoni, M. L., Frau, R., Trezza, V., Rana, G. L., Russo, R., Calignano, A., Gessa, G. L., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301061 · Cited by 236
Subjective Referral of the Timing for a Conscious Sensory Experience
Libet, B., Wright, E. W., FEINSTEIN, B., & Pearl, D. K. (1993) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-0355-1_9 · Cited by 232
Fortier, M., Luheshi, G. N., & Boksa, P. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.04.016 · Cited by 229
The contents of consciousness: A neuropsychological conjecture
Gray, J. A. (1995) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00040395 · Cited by 223
Depoortère, R., Dargazanli, G., Estenne‐Bouhtou, G., Coste, A., Lanneau, C., Desvignes, C., Poncelet, M., Héaulme, M., Santucci, V., Decobert, M., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300772 · Cited by 220
Men are more inhibited than women by weak prepulses
Swerdlow, N. R., Auerbach, P. P., Monroe, S. M., Hartston, H. J., Geyer, M. A., & BRAFF, D. L. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90079-s · Cited by 220
Self-citationMeasurement of Startle Response, Prepulse Inhibition, and Habituation
Geyer, M. A., & Swerdlow, N. R. (1998) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0807s03 · Cited by 219
Self-citationSwerdlow, N. R., & Geyer, M. A. (1993) · Behavioral Neuroscience · doi:10.1037//0735-7044.107.1.104 · Cited by 217
Self-citationPreattentional and attentional cognitive deficits as targets for treating schizophrenia
BRAFF, D. L., & Light, G. A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1848-0 · Cited by 213
Self-citationCui, C., Booker, T. K., Allen, R. S., Grady, S. R., Whiteaker, P., Marks, M. J., Salminen, O., Tritto, T., Butt, C. M., Allen, W. R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11045.2003 · Cited by 213
Boyce‐Rustay, J. M., & Holmes, A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301039 · Cited by 212
Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients
Weike, A. I., Bauer, U., & Hamm, A. O. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00229-2 · Cited by 206
Vanover, K. E., Weiner, D. M., Makhay, M. M., Veinbergs, I., Gardell, L. R., Lameh, J., Tredici, A. L. D., Piu, F., Schiffer, H. H., Ott, T. R., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.097006 · Cited by 206
Yee, B. K., Keist, R., von Boehmer, L., Studer, R., Benke, D., Hagenbuch, N., Dong, Y., Malenka, R. C., Fritschy, J.-M., Bluethmann, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508752102 · Cited by 201
Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex
Ellenbroek, B. A., Budde, S., & Cools, A. R. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00307-7 · Cited by 195
Duncan, G. E., Moy, S. S., Perez, A., Eddy, D. M., Zinzow-Kramer, W. M., Lieberman, J. A., Snouwaert, J. N., & Koller, B. H. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.01.008 · Cited by 194
Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia
Swerdlow, N. R., & Geyer, M. A. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90193-w · Cited by 192
Self-citationGene knockout of glycine transporter 1: Characterization of the behavioral phenotype
Tsai, G. E., Ralph, R. J., Martina, M., Bergeron, R., Berger-Sweeney, J. E., Dunham, K. S., Jiang, Z., Caine, S. B., & Coyle, J. T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402662101 · Cited by 192
Swerdlow, N. R., & Geyer, M. A. (1993) · Behavioral Neuroscience · doi:10.1037/0735-7044.107.1.104 · Cited by 192
Self-citationImpaired Prepulse Inhibition of Acoustic Startle in Obsessive-Compulsive Disorder
Hoenig, K., Hochrein, A., Quednow, B. B., Maier, W., & Wagner, M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.040 · Cited by 190
Light, G. A., Swerdlow, N. R., & BRAFF, D. L. (2007) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2007.19.10.1624 · Cited by 188
Self-citationEndogenous kynurenic acid disrupts prepulse inhibition.
Erhardt, S., Schwieler, L., Emanuelsson, C., & Geyer, M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.006 · Cited by 187
Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia
Szumlinski, K. K., Lominac, K. D., Kleschen, M. J., Oleson, E. B., Dehoff, M. H., Schwartz, M. K., Seeberg, P. H., Worley, P. F., & Kalivas, P. W. (2005) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2005.00120.x · Cited by 181
Swerdlow, N. R., Karban, B., Ploum, Y., Sharp, R. F., Geyer, M. A., & Eastvold, A. D. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01164-7 · Cited by 181
Self-citationBehavioural characterization of Vitamin D receptor knockout mice
Burne, T. H. J., McGrath, J. J., Eyles, D. W., & Mackay‐Sim, A. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.07.008 · Cited by 181
Wiedholz, L. M., Owens, W. A., Horton, R. E., Feyder, M. J., Karlsson, R.-M., Hefner, K. R., Sprengel, R., Celikel, T., Daws, L. C., & Holmes, A. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002056 · Cited by 180
Erbel-Sieler, C., Dudley, C., Zhou, Y., Wu, X., Estill, S. J., Han, T., Diaz-Arrastia, R., Brunskill, E. W., Potter, S. S., & McKnight, S. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405310101 · Cited by 178
Cannabidiol Reverses MK-801-Induced Disruption of Prepulse Inhibition in Mice
Long, L. E., Malone, D. T., & TAYLOR, D. A. H. B. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300838 · Cited by 177
Galici, R., Echemendia, N. G., Rodriguez, A. L., & Conn, P. J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.091074 · Cited by 175
Ralph, R. J., Varty, G. B., Kelly, M. A., Wang, Y.-M., Caron, M. G., Rubinstein, M., Grandy, D. K., Low, M. J., & Geyer, M. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04627.1999 · Cited by 174
Pen, G. L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00383-9 · Cited by 173
Kinney, G. G., Sur, C., Burno, M., Mallorga, P. J., Williams, J. B., Figueroa, D. J., Wittmann, M., Lemaire, W., & Conn, P. J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-20-07586.2003 · Cited by 172
Lovic, V., & Fleming, A. S. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00206-7 · Cited by 170
Behavioral characterization of dopamine D-sub-5 receptor null mutant mice.
Holmes, A., Hollon, T. R., Gleason, T., Liu, Z., Dreiling, J. L., Sibley, D. R., & Crawley, J. N. (2001) · Behavioral Neuroscience · doi:10.1037/0735-7044.115.5.1129 · Cited by 168
Boucher, A. A., Arnold, J. C., Duffy, L., Schofield, P. R., Micheau, J., & Karl, T. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0721-3 · Cited by 168
Swerdlow, N. R., Martinez, Z. A., Hanlon, F. M., Platten, A., Farid, M., Auerbach, P. P., BRAFF, D. L., & Geyer, M. A. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04325.2000 · Cited by 163
Self-citationLong‐term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism
Harris, L. W., Sharp, T., Gartlon, J. E., Jones, D. N. C., & Harrison, P. J. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02902.x · Cited by 162
Calkins, M. E., Dobie, D. J., Cadenhead, K. S., D, A. O. M., Freedman, R., Green, M. F., Greenwood, T. A., Gur, R. E., Gur, R. C., Light, G. A., et al. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl044 · Cited by 160
Self-citationKumari, V., Gray, J. A., Geyer, M. A., Ffytche, D. H., Soni, W., Mitterschiffthaler, M. T., Vythelingum, G. N., Simmons, A., Williams, S., & Sharma, T. (2003) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(02)00123-3 · Cited by 159
Rolipram: A specific phosphodiesterase 4 inhibitor with potential antipsychotic activity
Kanes, S., Tokarczyk, J., Siegel, S. J., Bilker, W. B., Abel, T. G., & Kelly, M. P. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.09.026 · Cited by 159
Lipina, T. V., Labrie, V., Weiner, I., & Roder, J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2210-x · Cited by 159
Afonso, V. M., Sison, M., Lovic, V., & Fleming, A. S. (2007) · Behavioral Neuroscience · doi:10.1037/0735-7044.121.3.515 · Cited by 152
Clinical and Sensorimotor Gating Effects of Ketamine in Normals
Duncan, E. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00240-2 · Cited by 150
Menstrual cycle phase effects on prepulse inhibition of acoustic startle
Jovanović, T., Szilagyi, S., Chakravorty, S., Fiallos, A. M., Lewison, B., Parwani, A., Schwartz, M. P., Gonzenbach, S., Rotrosen, J., & Duncan, E. (2004) · Psychophysiology · doi:10.1111/1469-8986.2004.00166.x · Cited by 148
Harte, M., Powell, S. B., Swerdlow, N. R., Geyer, M. A., & Reynolds, G. P. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0627-6 · Cited by 146
Self-citationMarquis, K. L., Sabb, A. L., Logue, S. F., Brennan, J. A., Piesla, M. J., Comery, T. A., Grauer, S. M., Ashby, C. R., Nguyen, H. Q., Dawson, L. A., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106989 · Cited by 145
Mackeprang, T., Kristiansen, K. T., & Glenthoj, B. Y. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01409-9 · Cited by 144
Romero, E., Ali, C., Molina‐Holgado, E., Castellano, B., Guaza, C., & Borrell, J. I. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301292 · Cited by 143
Nyffeler, M., Meyer, U., Yee, B. K., Feldon, J., & Knuesel, I. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.029 · Cited by 139
Detera‐Wadleigh, S. D., Badner, J. A., Yoshikawa, T., Sanders, A. R., Goldin, L. R., Turner, G., Rollins, D. Y., Moses, T. Y., Guroff, J. J., Kazuba, D. M., et al. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19970531)74:3 · Cited by 137
Sex differences in prepulse inhibition deficits in chronic schizophrenia
Kumari, V., Aasen, I., & Sharma, T. (2003) · Schizophrenia Research · doi:10.1016/j.schres.2003.09.010 · Cited by 136
Day-Wilson, K. M., Jones, D. N. C., Southam, E., Cilia, J., & Totterdell, S. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.04.048 · Cited by 135
Peri-pubertal maturation after developmental disturbance: A model for psychosis onset in the rat
Pen, G. L., Gourévitch, R., Hazane, F., Hoareau, C., Jay, T. M., & Krebs, M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.004 · Cited by 135
“Normal” personality correlates of sensorimotor, cognitive, and visuospatial gating
Swerdlow, N. R., Filion, D. L., Geyer, M. A., & Braff, D. L. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00138-s · Cited by 134
Self-citationG protein-coupled receptors in major psychiatric disorders
Catapano, L. A., & Manji, H. K. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.09.025 · Cited by 133
CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity.
Siuciak, J., Chapin, D., McCarthy, S. A., Guanowsky, V., Brown, J. A., Chiang, P., Marala, R., Patterson, T., Seymour, P., Swick, A., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.07.024 · Cited by 132
Razoux, F., Garcia, R., & Léna, I. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301057 · Cited by 132
The Muscarinic Receptor Agonist Xanomeline Has an Antipsychotic-Like Profile in the Rat
Stanhope, K. J., Mirza, N. R., Bickerdike, M. J., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29291-0 · Cited by 132
Preliminary evidence of an association between sensorimotor gating and distractibility in psychosis
Karper, L., Freeman, G., Grillon, C., Morgan, C. A., Charney, D. S., & Krystal, J. H. (1996) · Journal of Neuropsychiatry · doi:10.1176/jnp.8.1.60 · Cited by 130
LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric disease
Harrison, S. M., Reavill, C., Brown, G., Brown, J. T., Cluderay, J. E., Crook, B., Davies, C. H., Dawson, L. A., Grau, E., Heidbreder, C. A., et al. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.09.001 · Cited by 129
STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating
Fradley, R. L., O’Meara, G. F., Newman, R. J., Andrieux, A., Job, D., & Reynolds, D. S. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.05.012 · Cited by 127
Ouagazzal, A., Jenck, F., & Moreau, J.-L. (2001) · Psychopharmacology · doi:10.1007/s002130100763 · Cited by 126
Kumari, V., Soni, W., & Sharma, T. (2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.286 · Cited by 126
Early maternal deprivation and prepulse inhibition
Ellenbroek, B. A., & Cools, A. R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00794-3 · Cited by 125
Pillai-Nair, N., Panicker, A. K., Rodriguiz, R. M., Gilmore, K. L., Demyanenko, G. P., Huang, Z. J., Wetsel, W. C., & Maness, P. F. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0565-05.2005 · Cited by 125
Weil, Z. M., Hotchkiss, A. K., Gatien, M. L., Pieke-Dahl, S., & Nelson, R. J. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.09.016 · Cited by 125
Leumann, L., Feldon, J., Vollenweider, F. X., & Ludewig, K. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01344-6 · Cited by 123
Risbrough, V. B., Hauger, R. L., Roberts, A. L., Vale, W., & Geyer, M. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5760-03.2004 · Cited by 123
Spencer, C. M., Serysheva, E., Yuva‐Paylor, L. A., Oostra, B. A., Nelson, D. L., & Paylor, R. E. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl121 · Cited by 123
Kumari, V., Antonova, E., Geyer, M. A., Ffytche, D. H., Williams, S., & Sharma, T. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007139 · Cited by 121
Effects of the 5-HT7 receptor antagonist SB-258741 in animal models for schizophrenia
Pouzet, B., Didriksen, M., & Arnt, J. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00744-4 · Cited by 120
Reduced prepulse inhibition in unaffected siblings of schizophrenia patients
Kumari, V., Das, M., Zachariah, E., Ettinger, U., & Sharma, T. (2005) · Psychophysiology · doi:10.1111/j.1469-8986.2005.00346.x · Cited by 120
Knockout mouse model for Fxr2: a model for mental retardation
Bontekoe, C. J. M. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.487 · Cited by 120
Adage, T., Trillat, A., Quattropani, A., Perrin, D., Cavarec, L., Shaw, J., Guerassimenko, O., Giachetti, C., Greco, B. M., Chumakov, I. M., et al. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.06.006 · Cited by 119
Ralph, R. J., Paulus, M. P., Zhuang, X., Hen, R., & Geyer, M. A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01489-0 · Cited by 119
Abel, K. M., Waikar, M. V., Pedro, B. M., Hemsley, D., & Geyer, M. A. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200402 · Cited by 119
Park, C., Falls, W. A., Finger, J. H., Longo-Guess, C. M., & Ackerman, S. L. (2002) · Nature Genetics · doi:10.1038/ng908 · Cited by 118
Stability of the acoustic startle reflex, prepulse inhibition, and habituation in schizophrenia
Ludewig, K., Geyer, M. A., Etzensberger, M., & Vollenweider, F. X. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00198-0 · Cited by 115
Neurobiological Measures of Schizotypal Personality Disorder: Defining an Inhibitory Endophenotype?
Cadenhead, K. S., Light, G. A., Geyer, M. A., McDowell, J. E., & BRAFF, D. L. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.869 · Cited by 114
Self-citationWeiss, I. C., Iorio, L. D., Feldon, J., & Domeney, A. M. (2000) · Behavioral Neuroscience · doi:10.1037/0735-7044.114.2.364 · Cited by 111
Lower Prepulse Inhibition in Children With the 22q11 Deletion Syndrome
Sobin, C. A., Kiley‐Brabeck, K., & Karayiorgou, M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1090 · Cited by 111
Csomor, P., Stadler, R. R., Feldon, J., Yee, B. K., Geyer, M. A., & Vollenweider, F. X. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301421 · Cited by 110
Ralph, R. J., Masten, V. L., Otero-Corchón, V., Low, M. J., & Geyer, M. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09604.2002 · Cited by 110
Hippocampal α5 subunit-containing GABAA receptors modulate the expression of prepulse inhibition
Hauser, J., Rudolph, U., Keist, R., Möhler, H., Feldon, J., & Yee, B. K. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001554 · Cited by 109
Tenn, C., Fletcher, P., & Kapur, S. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00009-4 · Cited by 109
Pen, G. L., Kew, J. N. C., Alberati, D., Borroni, E., Heitz, M., & Moreau, J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00374-3 · Cited by 108
Ligneau, X., Landais, L., Perrin, D., Piriou, J., Uguen, M., Denis, E., Robert, P., Parmentier, R., Anaclet, C., Lin, J., et al. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.01.023 · Cited by 107
Low dose ketamine increases prepulse inhibition in healthy men
Abel, K. M., Allin, M. P. G., Hemsley, D. R., & Geyer, M. A. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00073-x · Cited by 106
Futamura, T., Kakita, A., Tohmi, M., Sotoyama, H., Takahashi, H., & Nawa, H. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001138 · Cited by 106
Postma, P., Gray, J. A., Sharma, T., Geyer, M. A., Mehrotra, R., Das, M., Zachariah, E., Hines, M., Williams, S., & Kumari, V. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0307-5 · Cited by 105
Zhang, L., Shirayama, Y., Iyo, M., & Hashimoto, K. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301313 · Cited by 105
Temporal order judgement for auditory and visual stimuli
Kanabus, M., Szela̧g, E., Rojek, E., & Pöppel, E. (2002) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2002-1443 · Cited by 105
Dopamine D1 Rather than D2 Receptor Agonists Disrupt Prepulse Inhibition of Startle in Mice
Ralph-Williams, R. J., Lehmann-Masten, V., & Geyer, M. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300017 · Cited by 105
Quednow, B. B., Wagner, M., Westheide, J., Beckmann, K., Bliesener, N., Maier, W., & Kühn, K.-U. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.012 · Cited by 104
Paine, T. A., Tomasiewicz, H. C., Zhang, K., & Carlezon, W. A. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.017 · Cited by 104
Ferguson, S. A., & Cada, A. M. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.12.014 · Cited by 103
Ouagazzal, A. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00282-2 · Cited by 103
Ralph, R. J., & Caine, S. B. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.074468 · Cited by 103
George, T. P., Termine, A., Sacco, K. A., Allen, T. M., Reutenauer, E. L., Vessicchio, J. C., & Duncan, E. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.05.022 · Cited by 103
Barr, A. M., Lehmann-Masten, V., Paulus, M., Gainetdinov, R. R., Caron, M. G., & Geyer, M. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300343 · Cited by 103
Oranje, B., van Oel, C. J., Wied, C. C. G., Verbaten, M. N., & Kahn, R. S. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200208000-00005 · Cited by 103
Aasen, I., Kolli, L., & Kumari, V. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105048890 · Cited by 101
Cadenhead, K. S., Carasso, B. S., Swerdlow, N. R., Geyer, M. A., & BRAFF, D. L. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00294-7 · Cited by 98
Self-citationKumari, V., Soni, W., & Sharma, T. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00276-6 · Cited by 98
Wang, C., McInnis, J., West, J. B., Bao, J., Anastasio, N. C., Guidry, J. A., Ye, Y., Salvemini, D., & Johnson, K. M. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041798 · Cited by 98
Sensory Modulation of the Blink Reflex in Patients With Blepharospasm
Gómez-Wong, E. (1998) · Archives of Neurology · doi:10.1001/archneur.55.9.1233 · Cited by 98
The heterozygous reeler mouse: behavioural phenotype
Podhorná, J., & Didriksen, M. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.10.033 · Cited by 97
Bitsios, P., Giakoumaki, S. G., Theou, K., & Frangou, S. (2006) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2006.04.001 · Cited by 97
Disruption of prepulse inhibition in mice lacking mGluR1
Brody, S. A., Conquet, F., & Geyer, M. A. (2003) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2003.03073.x · Cited by 97
Vollenweider, F. X., Remensberger, S., Hell, D., & Geyer, M. A. (1999) · Psychopharmacology · doi:10.1007/s002130050960 · Cited by 97
Sallinen, J., Höglund, I. P. J., Engström, M., Lehtimäki, J., Virtanen, R., Sirviö, J., Wurster, S., Savola, J., & Haapalinna, A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707005 · Cited by 97
Terry, A. V., Gearhart, D. A., Beck, W. D., Truan, J. N., Middlemore, M.-L., Williamson, L. N., Bartlett, M. G., Prendergast, M., Sickles, D. W., & Buccafusco, J. J. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.125625 · Cited by 97
Rehn, A., van den Buuse, M., Copolov, D., Briscoe, T. A., Lambert, G. W., & Rees, S. M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.047 · Cited by 95
Krebs-Thomson, K., Ruiz, E. M., Masten, V. L., Buell, M. R., & Geyer, M. A. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0566-1 · Cited by 95
Effect of d -amphetamine on prepulse inhibition of the startle reflex in humans
Hutchison, K. E., & Swift, R. M. (1999) · Psychopharmacology · doi:10.1007/s002130050964 · Cited by 95
Valls‐Solé, J., Muñoz, J. E., & Valldeoriola, F. (2004) · Clinical Neurophysiology · doi:10.1016/j.clinph.2004.02.014 · Cited by 95
Ma, J., & Leung, L.-W. S. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0667-x · Cited by 94
Calkins, M. E. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2003.12.005 · Cited by 94
Husum, H., Termeer, E. H., Mathé, A. A., Bolwig, T. G., & Ellenbroek, B. A. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00038-2 · Cited by 93
Abnormalities of the blink reflex in Gilles de la Tourette syndrome.
Smith, S. J., & Lees, A. J. (1989) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.7.895 · Cited by 91
Braff, D. L., Light, G. A., & Swerdlow, N. R. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.015 · Cited by 90
Self-citationBubeníková, V., Votava, M., Horáček, J., Páleníček, T., & Dockery, C. A. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.012 · Cited by 90
Porras‐García, E., Cendelín, J., del Toro, E. D., Vožeh, F., & Delgado-Garcia, J. M. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03940.x · Cited by 90
Midbrain pathways for prepulse inhibition and startle activation in rat
Yeomans, J. S., Lee, J. C., Yeomans, M. H., Steidl, S., & Li, L. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.06.025 · Cited by 90
Kumari, V., Antonova, E., Zachariah, E., Galea, A., Aasen, I., Ettinger, U., Mitterschiffthaler, M. T., & Sharma, T. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.03.002 · Cited by 89
Swerdlow, N. R. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00110-3 · Cited by 87
Self-citation
Research works printed but not linked: 9
- American Psychiatric Association (APA) (2000) Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR Fourth Edition (Text Revision)
- Braff et al (2008) One-year longitudinal study of 200 schizophrenia patients: no clinical, cognitive, neurophysiological or functional differences at intake in retested vs. non-retested patients. Abstr Society for Neuroscience (in press)
- Butler RW, Jenkins MA, Geyer MA, Braff D (1991) Wisconsin card sorting deficits and diminished sensorimotor gating in a discrete subgroup of schizophrenic patients. In: Tamminga CA, Schulz SC (eds) Advances in neuropsychiatry and psychopharmacology. New York, NY: Raven Press, pp 163–168
- Light GA et al (2007a) One year stability of neurophysiological and cognitive endophenotypes of schizophrenia. Proc Am Col Neuropsychopharmacology (in press)
- Light GA et al (2008) Preattentive sensory processing is associated with cognitive and psychosocial functioning in healthy adults. J Cog Neurosci 7:120–128
- Swerdlow NR (1996) Cortico–striatal substrates of cognitive, motor and sensory gating: Speculations and implications for psychological function and dysfunction. In: Panksepp J (ed) Advances in biological psychiatry, vol. 2. JAI Press Inc, Greenwich CT, pp 179–208
- Swerdlow NR et al (2003d) Prestimulus modification of the startle reflex: relationship to personality and physiological markers of dopamine function. Biol Psychology 62:17–26 · DOI
- Swerdlow NR et al (2005a) Effects of memantine on startle gating in normal adult men. Proc Am Coll Neuropsychopharm, Waikoloa, HI
- Swerdlow NR et al (2006g) The “low gating” phenotype in rats: antipsychotic sensitivity, heritability and sex differences. Biol Psychiatry 59:220S
Cited by
Sorted by citations
Animal models of neuropsychiatric disorders
Nestler, E. J., & Hyman, S. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2647 · Cited by 2,023
Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299
Prepulse inhibition and genetic mouse models of schizophrenia
Powell, S. B., Zhou, X., & Geyer, M. A. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.04.021 · Cited by 218
Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines
Ali, F., Gerhard, D. M., Sweasy, K., Pothula, S., Pittenger, C., Duman, R. S., & Kwan, A. C. (2020) · Nature Communications · doi:10.1038/s41467-019-13809-8 · Cited by 196
Milekic, M. H., Xin, Y., O’Donnell, A., Kumar, K. K., Bradley-Moore, M., Malaspina, D., Moore, H., Brunner, D., Ge, Y., Edwards, J., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.84 · Cited by 190
Metadata
- Authors
- Swerdlow, N. R., Weber, M., Qu, Y., Light, G. A., & Braff, D. L.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Swerdlow, Neal R.
- Venue
- Psychopharmacology
- Published
- 2008-06-21
- Volume
- 199
- Issue
- 3
- Pages
- 331-388
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- PMC
- PMC2771731
- OpenAlex
- W2062472783
- Cited by
- 529
- References
- 478
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 13 · 2023: 18 · 2022: 19 · 2021: 23 · 2020: 31 · 2019: 21 · 2018: 23 · 2017: 30 · 2016: 38 · 2015: 42 · 2014: 31 · 2013: 51 · 2012: 38
- FWCI
- 5.46
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Pfizer
- National Alliance for Research on Schizophrenia and Depression
- ACADIA Pharmaceuticals
- Allergan
- Pfizer Pharmaceuticals
- National Institute of Mental Health (MH 53484, MH68366, R01MH069589, MH65571, MH69589, MH42228, R01MH068366, R37MH042228, R01MH053484, R01MH042228, R01MH059803, MH 79777, MH 58903, R01MH065571, R01MH079777)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- prepulse inhibition, schizophrenia, sensorimotor gating, translational model, animal models of schizophrenia, startle response, inhibition mechanism, preclinical drug screening, quantitative phenotypes, model organisms
- MeSH terms
- Animals, Disease Models, Animal, Humans, Models, Psychological, Schizophrenia, Schizophrenic Psychology, Reflex, Startle, Antipsychotic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review